FMP2.1/AS02A

BIOLOGICAL3 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

MalariaPlasmodium Falciparum Malaria

Phase 1

FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali

CompletedNCT00349713

U.S. Army Medical Research and Development CommandMalaria, Plasmodium Falciparum Malaria

Start: 2004-11-30End: 2006-12-31Updated: 2017-07-24

Phase I Pediatric FMP2.1/AS02A Trial in Mali

CompletedNCT00358332

U.S. Army Medical Research and Development CommandPlasmodium Falciparum Malaria

Start: 2006-11-30End: 2007-12-31Updated: 2011-10-24

Phase 2

Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

CompletedNCT00460525

U.S. Army Medical Research and Development CommandPlasmodium Falciparum Malaria

Start: 2007-05-31End: 2009-07-31Updated: 2018-11-09

Related Papers

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine

PLoS ONE2017-03-1015 citations

Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate.

2016-04-157 citations

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

PLoS ONE2013-11-1842 citations

A field trial to assess a blood-stage malaria vaccine.

2011-09-01298 citations

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.

2010-02-0447 citations

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

2009-04-23165 citations